Our functional assays using a T cell-mediated cancer cell killing assay demonstrated that ALDH1A1 deficiency in various tumor cells significantly enhances T cell-mediated cytotoxicity by suppressing tumor glycolytic levels. The gene discussed is ALDH1A1; the disease is neoplasm.